- The United States Congress has come to the rescue of Americans by agreeing on $900 billion (around R13 313 421 000 000) coronavirus relief package as pandemic hits harder
- Businesses and individuals will be receiving monetary assistance from the government as the world continues to battle the deadly Covid-19
- There is a temporary $300 per week (around R4 436) supplemental benefit for unemployed Americans and $600 (around R8 873) direct stimulus payments to most Americans
The United States Congress has agreed on a $900 billion (around R13 313 421 000 000) Covid-19 package for the citizens of the country as well as businesses.
The disclosure was made on Sunday, 20 December by the Senate majority leader, Mitch McConnell, Daily Mail reports. The House will be voting on the legislation on Monday, 21 December, and Senate action will follow.
Most adults and children will be receiving $600 (around R8 873) each. There is also an arrangement to pay unemployed citizens $300 (around R4 436) as an unemployment supplement every week.
The benefit could begin by 27 December 2020 and run through 14 March 2021.
There is an arrangement of $45 billion (around R665 billion) as transportation assistance, including $15 billion (around R221 billion) to United States passenger airlines for payroll assistance.
The benefit also covers a $25 billion (around R369 billion) rental assistance to families struggling to stay in their homes, and an extension of the eviction moratorium.
In other coronavirus related news in the US, Briefly.co.za recently reported on the US government giving the green light for use of the Pfizer vaccine. This after a 23-member panel advising the United States (US) Food and Drug Administration (FDA) agreed on the use of Pfizer vaccine in the protection against Covid-19, which has ravaged the country with over 15.7 million cases.
The Pfizer-BioNTech vaccine which has been proven to be over 90% effective has been approved in several countries, including the United Kingdom (UK), Canada, Bahrain and Saudi Arabia.
The FDA, an agency within the US Department of Health and Human Services, said in a statement on Thursday, 10 December that the final decision about whether to authorise the vaccine for emergency use would be made by FDA’s career officials.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!